Pinkas Jan — SEC Form 4 filings

SEC reporting owner CIK 2077126. 4 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-07-16 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CRESCENT BIOPHARMA, INC. (CBIO)Chief Scientific Officer42 legs · 1,946 sh · $34,9494

Form 4 filings — Pinkas Jan

FiledFormIssuerReported transactionsSource
2026-09-184CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 658 @ $17.90EDGAR
2026-06-234CRESCENT BIOPHARMA, INC. (CBIO)Sale (S): 1,288 @ $17.99EDGAR
2025-12-174CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 17,507 · Grant/award (A): 5,000 · Grant/award (A): 70,025 (derivative) @ $0EDGAR
2025-07-164CRESCENT BIOPHARMA, INC. (CBIO)Grant/award (A): 142,474 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2077126 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →